{"id":5671,"date":"2017-08-19T20:10:26","date_gmt":"2017-08-20T00:10:26","guid":{"rendered":"http:\/\/localhost:10028\/practiceareas\/actos-lawsuit\/"},"modified":"2022-06-21T16:54:07","modified_gmt":"2022-06-21T20:54:07","slug":"actos-demanda","status":"publish","type":"practiceareas","link":"https:\/\/napolilaw.lemonadestand.org\/es\/areas-de-practica-2\/actos-demanda\/","title":{"rendered":"Demanda Actos"},"content":{"rendered":"<h2 class=\"update-highlight\" style=\"text-align: center; background-color: red;\">YA NO ACEPTAMOS CASOS DE ACTOS<\/h2>\n<h3><\/h3>\n<h3>Presentar una Demanda Actos por Lesiones Causadas por Actos (Pioglitazona)<\/h3>\n<p>Actos (pioglitazone) is a treatment for type 2 diabetes. Available only by prescription, pioglitazone is in a class of medications called thiazolidinediones. Thiazolidinediones work in the body to balance the blood sugar by increasing the cells\u2019 receptiveness to insulin. Patients may have taken this drug under the brand name Actos or under other names such as Actoplus Met (pioglitazone and metformin) or Duetact (pioglitazone and glimepiride). People experiencing adverse side effects have begun filing actos lawsuits.<\/p>\n<p>More than two million Americans with type 2 diabetes take Actos. Many are increasingly concerned (and rightfully so) about potential side effects. Actos is the most prescribed medication for the treatment of type 2 diabetes, generating 3.4 billion in sales in 2009. However, recent studies have shown a link between this medication and bladder cancer. Some users are therefore considering their legal options in filing an Actos lawsuit against the manufacturer, Takeda Pharmaceuticals. With the serious side effects they have experienced, recovering financial compensation can make a significant difference in their ability to pay for medical care, lost earnings and other financial, physical and emotional losses or injuries.<\/p>\n<p>&nbsp;<\/p>\n<h3>Efectos secundarios graves relacionados con Actos<\/h3>\n<p>People taking this medication for treatment of type 2 diabetes should be aware that they are at risk for developing serious side effects, including new or worsening heart failure and liver problems. The government has also warned of pioglitazone and bladder cancer risks.<\/p>\n<p>The U.S. Food and Drug Administration (FDA) issued a warning in September of 2010 about Actos and bladder cancer after reviewing data from a ten-year study conducted by Takeda Pharmaceutical Company, the drug manufacturer. Data showed a link between Actos and bladder cancer. People taking the highest doses of the drug, or who had taken the drug for a long time, were at the highest risk of developing bladder cancer. Many of those victims have filed an Actos lawsuit.<\/p>\n<p><strong>Adem\u00e1s del c\u00e1ncer de vejiga, Actos puede presentar riesgos adicionales que pueden ser da\u00f1inos, permanentes o potencialmente mortales.<\/strong><\/p>\n<ul>\n<li><strong>Riesgo de fractura \u00f3sea: <\/strong>Actos puede aumentar el riesgo de fractura \u00f3sea en dos o m\u00e1s veces. Se ha demostrado que el riesgo es mayor en las mujeres, pero puede incluir a los hombres y ocurre principalmente en los brazos, la parte inferior de las piernas o las caderas y probablemente est\u00e9 relacionado con el efecto de Actos en el crecimiento del tejido \u00f3seo.<\/li>\n<li><strong>Insuficiencia card\u00edaca congestiva - <\/strong>Actos puede duplicar la posibilidad de insuficiencia card\u00edaca. A partir de 2007, la FDA exigi\u00f3 que se incluyera una &quot;advertencia de recuadro negro&quot; en la informaci\u00f3n de Actos que se\u00f1alara el riesgo de insuficiencia card\u00edaca congestiva.<\/li>\n<li><strong>Enfermedad Renal Cr\u00f3nica \u2013<\/strong> Tomar Actos puede aumentar el riesgo de enfermedad renal hasta en un 400 por ciento. La enfermedad renal causa presi\u00f3n arterial alta, empeora los problemas card\u00edacos y puede resultar en un reemplazo de ri\u00f1\u00f3n o enfermedad renal en etapa terminal (ESRD) que puede causar la muerte.<\/li>\n<li><strong>Edema macular \u2013 <\/strong>El edema macular puede resultar en da\u00f1o a la retina y ceguera permanente. El riesgo de edema macular es mayor en pacientes diab\u00e9ticos. Un estudio de 2009 mostr\u00f3 que el medicamento duplica el riesgo de desarrollar edema macular y ceguera.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>Cuando los resultados de un estudio de Actos realizado por el gobierno franc\u00e9s tambi\u00e9n encontraron un v\u00ednculo entre Actos y el c\u00e1ncer de vejiga en junio de 2011, los reguladores de Francia y Alemania emitieron un retiro del mercado de Actos, retirando el medicamento del mercado. En respuesta, la FDA requiri\u00f3 un cambio en la etiqueta de efectos secundarios de Actos para advertir del riesgo a las personas que toman el medicamento para su diabetes tipo 2. La FDA no emiti\u00f3 un retiro de Actos en los EE. UU.<\/p>\n<p>&nbsp;<\/p>\n<h3>S\u00edntomas peligrosos<\/h3>\n<p>Before the labeling change, patients taking Actos may not have known about or understood the link between Actos and bladder cancer, and this is why many are pursuing an Actos lawsuit. They may have even experienced potential symptoms of bladder cancer without realizing what they were or that they could have been linked to Actos use.<\/p>\n<p>Inform your doctor immediately if you took Actos for your type 2 diabetes and are experiencing such symptoms as:<\/p>\n<div class=\"two-col\">\n<ul>\n<li>Sangre en la orina<\/li>\n<li>Urgencia urinaria<\/li>\n<li>Dolor al orinar<\/li>\n<li>Dolor de espalda o abdominal<\/li>\n<li>Insuficiencia card\u00edaca nueva o peor;<\/li>\n<li>Edema;<\/li>\n<li>problemas hep\u00e1ticos;<\/li>\n<li>C\u00e1ncer de vejiga;<\/li>\n<li>hipoglucemia;<\/li>\n<li>Huesos rotos\/fracturas;<\/li>\n<li>edema macular; y<\/li>\n<li>La ovulaci\u00f3n que conduce al embarazo.<\/li>\n<\/ul>\n<\/div>\n<p>&nbsp;<\/p>\n<h3>Demandas de Actos: lo que necesita saber<\/h3>\n<p>Victims of harm caused as a direct result of taking Actos have the right to take legal action against Takeda Pharmaceuticals. An Actos lawsuit may seek damages based on Takeda\u2019s negligence. These Actos lawsuits allege that Takeda failed to properly warn of the risks of taking Actos, continued to manufacture and market the drug despite known risks, manufactured a defective product, failed to properly test Actos, or\/and did not reveal Actos testing data to the public.<\/p>\n<p>There are class action lawsuits currently pending against Actos\u2019 manufacturer. You may have the right to join an existing Actos lawsuit, or file a civil action independently.<\/p>\n<p>Working with an Actos attorney will ensure that you have the information to properly present your case for damages in the Actos litigation.<\/p>\n<p>&nbsp;<\/p>\n<h3>Comun\u00edquese con nuestra oficina para una revisi\u00f3n gratuita de su caso<\/h3>\n<p>Si tom\u00f3 pioglitazona para el tratamiento de la diabetes tipo 2 y luego su m\u00e9dico le diagnostic\u00f3 c\u00e1ncer de vejiga, es posible que tenga motivos para presentar una demanda por c\u00e1ncer de vejiga Actos. Es posible que la compa\u00f1\u00eda farmac\u00e9utica no le haya advertido adecuadamente sobre el v\u00ednculo entre Actos y el c\u00e1ncer de vejiga. Es posible que le hayan recetado err\u00f3neamente este medicamento. A <a href=\"\/es\/areas-de-practica-2\/litigio-farmaceutico\/\">litigio farmac\u00e9utico<\/a> El abogado de Napoli Shkolnik, PLLC puede brindarle una consulta legal gratuita para conocer sus derechos. Nuestros abogados han ayudado a miles de personas lesionadas por medicamentos recetados defectuosos. Queremos representarlo en su demanda Actos. No tenemos miedo de enfrentarnos a la farmac\u00e9utica para luchar por lo que te importa, justicia e indemnizaci\u00f3n. Para obtener m\u00e1s informaci\u00f3n sobre su derecho a la acci\u00f3n legal, ll\u00e1menos hoy para programar una consulta de caso.<\/p>","protected":false},"excerpt":{"rendered":"<p>YA NO ACEPTAMOS CASOS DE ACTOS Presentaci\u00f3n de una demanda de Actos por lesiones causadas por Actos (pioglitazona) Actos (pioglitazona) es un tratamiento para la diabetes tipo 2. Disponible s\u00f3lo con receta m\u00e9dica,\u2026<\/p>","protected":false},"featured_media":0,"menu_order":49,"template":"","practiceareas_category":[743],"class_list":["post-5671","practiceareas","type-practiceareas","status-publish","hentry","practiceareas_category-pharmaceutical-litigation"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/es\/wp-json\/wp\/v2\/practiceareas\/5671","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/es\/wp-json\/wp\/v2\/practiceareas"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/es\/wp-json\/wp\/v2\/types\/practiceareas"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/es\/wp-json\/wp\/v2\/practiceareas\/5671\/revisions"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/es\/wp-json\/wp\/v2\/media?parent=5671"}],"wp:term":[{"taxonomy":"practiceareas_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/es\/wp-json\/wp\/v2\/practiceareas_category?post=5671"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}